Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Launchpad
Be early to the next big token project
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
HealthEquity Exceeds Q4 Expectations, Raises FY2027 Guidance
Utah Draper - HealthEquity Inc. (NASDAQ: HQY) reported fourth-quarter results that exceeded analyst expectations, with adjusted earnings per share of $0.95, up from the consensus estimate of $0.90 by $0.05. The company’s stock rose 1.3% in after-hours trading on Tuesday.
Revenue reached $334.6 million, surpassing the $331.93 million forecast, representing a 7% increase from $311.8 million in the same period last year.
This health savings account management company reported net income of $49.7 million, with diluted earnings per share of $0.58, compared to $26.4 million and $0.30 per share in the same quarter last year. Adjusted EBITDA grew 23% to $132.9 million, with profit margins expanding from 35% last year to 40%.
HealthEquity President and CEO Scott Cutler stated, “After achieving record-breaking new HSA sales and significant profit margin expansion, we are raising our guidance for fiscal 2027. We have now added 1 million new HSA accounts for the second consecutive year, ending fiscal 2026 with 17.8 million total accounts and over $36 billion in HSA assets, laying a foundation for our continued growth.”
For fiscal 2027, the company issued guidance expecting revenue between $1.405 billion and $1.415 billion, with a midpoint of $1.41 billion, slightly above analyst expectations. Adjusted earnings per share are projected to be between $4.56 and $4.65, with a midpoint of $4.61. Adjusted EBITDA is expected to be between $618 million and $628 million.
For the full fiscal year 2026, HealthEquity reported revenue of $1.31 billion, a 9% increase from $1.2 billion in 2025. Net income soared 123% to $215.2 million, with adjusted earnings per share up 28% to $4.00. During the year, the company returned $301.7 million to shareholders through stock buybacks.
This article was translated with the assistance of artificial intelligence. For more information, please see our Terms of Use.